CD4 and neoplasm: Zhang et al. recently reported that MSI-H was differentially associated with tumor immune microenvironment, and MSI-H CRC exhibited significantly altered immune phenotype, including an increase of CD8 T cells and alteration of CD4 functional subsets in favor of immune protection [31].